Francesco De Rubertis

age:

54 years

appointments:

18 active

9 prior

primary industry:

Scientific research and development

about Francesco

Since 2019, Mr De Rubertis has been a director of 27 companies, the current directorship have a combined turnover of approximately £19.2m.

Combined Valuation

£541.9m

Combined Turnover

£19.2m

active directorships over time

company
turnover
valuation
start
end
status
role
centessa pharmaceuticals plc£5.4m£408.2mNov 2020-OpenDirector
centessa pharmaceuticals (uk) limited-£87.7mDec 2020-OpenDirector
z factor limited-£9.4mOct 2020-OpenDirector
imhotex limited£293.7k£7.6mFeb 2020-OpenDirector
levicept ltd£9.3m£5.6mNov 2020-OpenDirector
kaerus bioscience limited£180.2k£4.1mJun 2021-OpenDirector
perfect balance bio limited£374.9k£2.4mOct 2020-OpenDirector
ottimo pharma limited£385.2k£1.9mNov 2020-OpenDirector
ultrahuman one limited£346.5k£584.4kNov 2020-OpenDirector
ultrahuman thirteen limited£346.2k£583.9kNov 2020-OpenDirector
ultrahuman twelve limited£343.8k£579.7kNov 2020-OpenDirector
ultrahuman nine limited£342.5k£577.6kNov 2020-OpenDirector
ultrahuman ten limited£342.4k£577.5kNov 2020-OpenDirector
ultrahuman fourteen limited£324.7k£512kNov 2020-OpenDirector
ultrahuman seven limited£306.9k£456.4kNov 2020-OpenDirector
pandeia therapeutics limited£145.2k£169.7kSep 2019-OpenDirector
bplete limited-£2Nov 2023-OpenDirector